Serum S100B protein after electroconvulsive therapy in patients with depression

Keyphrases

• 6-month Follow-up 8%
• Biomarkers of Response 8%
• Cell Wall Proteins 8%
• Clinical Effect 16%
• Clinical Outcomes 16%
• Depression Severity 8%
• Depressive-like Behavior 8%
• Electroconvulsive Therapy 100%
• Glial Cells 8%
• HAMD-17 8%
• Hamilton Depression Rating Scale (HAM-D) 8%
• Linear Mixed Model 8%
• Neurotrophic Effect 8%
• Non-associated 8%
• Partial Correlation 8%
• Patients with Depression 100%
• S100 Proteins 100%
• S100B 100%
• Spearman Correlation 8%
• State Marker 8%
• Therapy Response 16%
• Therapy-related 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Cell Protein 50%
• Depression 50%
• Mixed Model 50%
• Protein S100B 100%

Neuroscience

• Cell Protein 8%
• Depression 8%
• Electroconvulsive Therapy 100%
• Glial Cells 8%
• Hamilton Rating Scale for Depression 8%
• Protein S100B 100%